# International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)

> **NCT01119716** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 4658 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01119716
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-25
- **Primary completion:** 2013-02-15
- **Final completion:** 2013-02-15
- **Target enrollment:** 4658 (ACTUAL)
- **Last updated:** 2024-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119716, "International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01119716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*